IGWM
UTHR icon

ICA Group Wealth Management’s United Therapeutics UTHR Stock Holding History

ICA Group Wealth Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-8
Closed -$1.84K – 1309
2024
Q1 		$1.84K Sell
8
-21
-72% -$4.74K ﹤0.01% 1191
2023
Q4 		$6.38K Buy
+29
New +$6.68K ﹤0.01% 966
2023
Q3 		– Sell
-29
Closed -$6.4K – 1178
2023
Q2 		$6.4K Hold
29
– – ﹤0.01% 924
2023
Q1 		$6.5K Hold
29
– – ﹤0.01% 894
2022
Q4 		$8.06K Buy
+29
New +$7.32K ﹤0.01% 864

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ICA Group Wealth Management's UTHR Position: Q2 2024 in Review

ICA Group Wealth Management sold out of United Therapeutics (UTHR) in Q2 2024, closing a stake of 8 shares — an estimated $1.84K sold.

ICA Group Wealth Management first reported a position in UTHR in Q4 2022 and held it in 5 quarters. The position peaked at $8.06K in Q4 2022. 566 funds tracked by Wall St. Rank hold UTHR as of Q2 2024.

  • ICA Group Wealth Management reported no remaining United Therapeutics position as of Q2 2024 after selling out during the quarter.
  • ICA Group Wealth Management sold 8 United Therapeutics shares in Q2 2024, an estimated $1.84K.
  • ICA Group Wealth Management first reported a position in United Therapeutics in Q4 2022 and held it in 5 quarters.
  • ICA Group Wealth Management's United Therapeutics position peaked at $8.06K in Q4 2022.
  • 566 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2024.

Based on ICA Group Wealth Management's 13F filing for Q2 2024, filed 8 Aug 2024.